Pakistan vs Sudan: Access to anti-retroviral drugs, male
Pakistan
14.0%
in 2024
Sudan
23.0%
in 2024
Pakistan rank
140th
Sudan rank
138th
Access to anti-retroviral drugs, male over time
- Pakistan
- Sudan
How they compare
Sudan currently reports 23.0% against 14.0% in Pakistan, a difference of 9.0%.
That makes Sudan's figure about 1.6 times Pakistan's.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Sudan ahead.
Pakistan ranks 140th and Sudan ranks 138th of 141 countries.
Sudan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Pakistan | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.1% | 2.1% | 1.0% | Sudan |
| 2010s | 4.4% | 17.0% | 12.6% | Sudan |
| 2020s | 10.6% | 25.0% | 14.4% | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Pakistan or Sudan?
- Sudan, at 23.0% against 14.0% in Pakistan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Pakistan and Sudan?
- 9.0%, with Sudan ahead.
- How many years of comparable data are there for Pakistan and Sudan?
- 22 years are reported by both, from 2000 to 2024.
- How do Pakistan and Sudan rank globally for access to anti-retroviral drugs, male?
- Pakistan ranks 140th and Sudan ranks 138th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.